Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
Condition(s):Neurofibromatosis 1Last Updated:November 22, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Neurofibromatosis 1Last Updated:November 22, 2016Completed
Condition(s):Blood Platelets ProteomeLast Updated:June 16, 2015Completed
Condition(s):Actinic PorokeratosisLast Updated:December 7, 2023Completed
Condition(s):Alveolar Bone Loss, Chronic Periodontitis, Lovestatin Gel, RegenerationLast Updated:July 5, 2019Completed
Condition(s):Syndromic Ichthyoses; CHILD Syndrome; Smith Lemli Opitz Syndrome; Conradi SyndromeLast Updated:May 19, 2015Withdrawn
Condition(s):Precancerous Condition; Stage 0 Melanoma; Stage I Melanoma; Stage II MelanomaLast Updated:October 31, 2014Completed
Condition(s):Neurofibromatosis Type 1Last Updated:March 12, 2018Completed
Condition(s):StrokeLast Updated:May 9, 2016Completed
Condition(s):Severe Persistent AsthmaLast Updated:June 21, 2013Withdrawn
Condition(s):Breast Cancer; Radiation ToxicityLast Updated:June 20, 2013Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.